Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Plasma Cell × Pharmaceutical Preparations × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Recurrence 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Prostatic Neoplasms 1 Pleural Effusion, Malignant 1 Pancreatic Neoplasms 1 Neoplasms 1 NSCLC 1 Myeloproliferative Disorders 1 Mesothelioma, Malignant 1 Melanoma 1 Lymphoma 1 Lymphedema 1 Immunoglobulin Light-chain Amyloidosis 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 Glioblastoma 1 Fibrosis 1 Fallopian Tube Neoplasms 1 Dysplastic Nevus Syndrome 1 Cholangiocarcinoma 1 Central Nervous System Neoplasms 1 Carcinoma, Ovarian Epithelial 1 BRAF V600 Colorectal Cancer 1 Anxiety Disorders 1

Interventions

Dexamethasone 16 Lenalidomide 12 Bortezomib 9 Cyclophosphamide 7 carfilzomib 6 Whole-Body Irradiation 6 Melphalan 6 fludarabine 5 daratumumab 5 Tacrolimus 5 Mycophenolic Acid 5 Calcium Dobesilate 5 pomalidomide 3 fludarabine phosphate 3 belantamab mafodotin 3 Radiotherapy 3 gamma-Globulins 2 elotuzumab 2 Trimethoprim, Sulfamethoxazole Drug Combination 2 Sirolimus 2 Prednisone 2 Immunoglobulins, Intravenous 2 Hematopoietic Stem Cell Transplantation 2 Etoposide 2 venetoclax 1 thymoglobulin 1 siltuximab 1 poly ICLC 1 pembrolizumab 1 ixazomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡